215 related articles for article (PubMed ID: 31665380)
1. Plasma Ceramide Species Are Associated with Diabetes Risk in Participants of the Strong Heart Study.
Fretts AM; Jensen PN; Hoofnagle A; McKnight B; Howard BV; Umans J; Yu C; Sitlani C; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
J Nutr; 2020 May; 150(5):1214-1222. PubMed ID: 31665380
[TBL] [Abstract][Full Text] [Related]
2. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study.
Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Howard BV; Umans JG; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
Cardiovasc Diabetol; 2022 Aug; 21(1):167. PubMed ID: 36042511
[TBL] [Abstract][Full Text] [Related]
3. Plasma Ceramides and Sphingomyelins and Sudden Cardiac Death in the Cardiovascular Health Study.
Bockus LB; Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
JAMA Netw Open; 2023 Nov; 6(11):e2343854. PubMed ID: 37976059
[TBL] [Abstract][Full Text] [Related]
4. Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk.
Lemaitre RN; Jensen PN; Hoofnagle A; McKnight B; Fretts AM; King IB; Siscovick DS; Psaty BM; Heckbert SR; Mozaffarian D; Sotoodehnia N
Circ Heart Fail; 2019 Jul; 12(7):e005708. PubMed ID: 31296099
[TBL] [Abstract][Full Text] [Related]
5. Plasma ceramides containing saturated fatty acids are associated with risk of type 2 diabetes.
Fretts AM; Jensen PN; Hoofnagle AN; McKnight B; Howard BV; Umans J; Sitlani CM; Siscovick DS; King IB; Djousse L; Sotoodehnia N; Lemaitre RN
J Lipid Res; 2021; 62():100119. PubMed ID: 34555371
[TBL] [Abstract][Full Text] [Related]
6. Plasma Ceramides and Sphingomyelins in Relation to Atrial Fibrillation Risk: The Cardiovascular Health Study.
Jensen PN; Fretts AM; Hoofnagle AN; Sitlani CM; McKnight B; King IB; Siscovick DS; Psaty BM; Heckbert SR; Mozaffarian D; Sotoodehnia N; Lemaitre RN
J Am Heart Assoc; 2020 Feb; 9(4):e012853. PubMed ID: 32019406
[TBL] [Abstract][Full Text] [Related]
7. Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study.
Lemaitre RN; Yu C; Hoofnagle A; Hari N; Jensen PN; Fretts AM; Umans JG; Howard BV; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; McKnight B
Diabetes; 2018 Aug; 67(8):1663-1672. PubMed ID: 29588286
[TBL] [Abstract][Full Text] [Related]
8. Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study.
Fretts AM; Jensen PN; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
Clin Chem; 2021 Nov; 67(12):1650-1659. PubMed ID: 34580702
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease.
You Q; Peng Q; Yu Z; Jin H; Zhang J; Sun W; Huang Y
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830858
[TBL] [Abstract][Full Text] [Related]
10. Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study.
Jensen PN; Fretts AM; Yu C; Hoofnagle AN; Umans JG; Howard BV; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; McKnight B; Lemaitre RN
EBioMedicine; 2019 Mar; 41():44-49. PubMed ID: 30594552
[TBL] [Abstract][Full Text] [Related]
11. Ceramide stearic to palmitic acid ratio predicts incident diabetes.
Hilvo M; Salonurmi T; Havulinna AS; Kauhanen D; Pedersen ER; Tell GS; Meyer K; Teeriniemi AM; Laatikainen T; Jousilahti P; Savolainen MJ; Nygård O; Salomaa V; Laaksonen R
Diabetologia; 2018 Jun; 61(6):1424-1434. PubMed ID: 29546476
[TBL] [Abstract][Full Text] [Related]
12. Association between specific plasma ceramides and high-sensitivity C-reactive protein levels in postmenopausal women with type 2 diabetes.
Mantovani A; Altomari A; Lunardi G; Bonapace S; Lippi G; Bonnet F; Targher G
Diabetes Metab; 2020 Sep; 46(4):326-330. PubMed ID: 31185304
[TBL] [Abstract][Full Text] [Related]
13. Plasma Ceramides and Sphingomyelins of Pediatric Patients Increase in Primary Ciliary Dyskinesia but Decrease in Cystic Fibrosis.
Bal Topçu D; Tugcu G; Ozcan F; Aslan M; Yalcinkaya A; Polat SE; Hizal M; Yalcin EE; Ersoz DD; Ozcelik U; Kiper N; Lay I; Oztas Y
Lipids; 2020 May; 55(3):213-223. PubMed ID: 32120452
[TBL] [Abstract][Full Text] [Related]
14. Plasma cross-gestational sphingolipidomic analyses reveal potential first trimester biomarkers of preeclampsia.
Dobierzewska A; Soman S; Illanes SE; Morris AJ
PLoS One; 2017; 12(4):e0175118. PubMed ID: 28384202
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of LC-MS/MS method for determination of very long acyl chain (C22:0 and C24:0) ceramides in human plasma.
Jiang H; Hsu FF; Farmer MS; Peterson LR; Schaffer JE; Ory DS; Jiang X
Anal Bioanal Chem; 2013 Sep; 405(23):7357-65. PubMed ID: 23857140
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipids and physical function in the Atherosclerosis Risk in Communities (ARIC) study.
Li D; Alam AB; Yu F; Kucharska-Newton A; Windham BG; Alonso A
Sci Rep; 2021 Jan; 11(1):1169. PubMed ID: 33441925
[TBL] [Abstract][Full Text] [Related]
18. Plasma sphingolipids in patients with sickle cell disease: Multiple-site vaso-occlusive crises could be associated with lower sphingolipid levels.
Alp G; Oztas Y; Yalcinkaya A; Ozel S; Yildirim N; Unal S
Lipids; 2024 May; 59(3):75-82. PubMed ID: 38332401
[TBL] [Abstract][Full Text] [Related]
19. Blood sphingolipidomics in healthy humans: impact of sample collection methodology.
Hammad SM; Pierce JS; Soodavar F; Smith KJ; Al Gadban MM; Rembiesa B; Klein RL; Hannun YA; Bielawski J; Bielawska A
J Lipid Res; 2010 Oct; 51(10):3074-87. PubMed ID: 20660127
[TBL] [Abstract][Full Text] [Related]
20. Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes.
Mantovani A; Csermely A; Sani E; Beatrice G; Petracca G; Lunardi G; Bonapace S; Lippi G; Targher G
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
